期刊文献+

浅蓝菌素联合吉西他滨对人胰腺癌细胞BxPC3增殖与凋亡的影响 被引量:1

Effect of cerulenin combined with gemcitabine on proliferation and apoptosis in human pancreatic cell line BxPC3
原文传递
导出
摘要 目的 观察浅蓝菌素联合吉西他滨对胰腺癌细胞BxPC3生长抑制的协同作用,探讨其机制.方法 以10μg/ml浅蓝菌素、20μmol/L吉西他滨、10 μg/ml浅蓝菌素+20μg/L吉西他滨分别处理对数生长期的人胰腺癌BxPC3细胞48 h,以不经药物处理的细胞作为对照.应用CCK-8法检测各组细胞增殖,AnnexinV/PI双染法检测细胞早期凋亡率,RT-PCR法检测Bcl-2、Bax mRNA表达,蛋白质印迹法检测Bcl-2、Bax蛋白表达.结果 对照组、浅蓝菌素组、吉西他滨组、联合处理组48 h的生长抑制率分别为0、(51.28±1.84)%、(53.59±1.62)%、(84.57 ±1.01)%;细胞早期凋亡率为(0.83±0.31)%、(31.37±1.04)%、(38.33±0.75)%、(69.43±0.83)%;BxPC3细胞Bcl-2 mRNA表达量分别为0.67±0.01、0.44±0.01、0.36±0.08、0.27 ±0.07;Bax mRNA表达量为0.14±0.01、0.31±0.02、0.32±0.03、0.91±0.06;Bcl-2 mRNA/Bax mRNA比值为4.78±0.13、1.39±0.04、1.15±0.02、0.30±0.02;Bcl-2蛋白表达量分别为1.24±0.04、0.51±0.02、0.42±0.02、0.13±0.01;Bax蛋白表达量为0.20±0.05、0.47±0.01、0.54±0.01、1.21±0.03;Bcl-2/Bax比值为6.00±0.11、1.11±0.01、0.77±0.03、0.10±0.06.各处理组与对照组,联合处理组与单药处理组的差异均有统计学意义(P值均<0.01).结论 浅蓝菌素与吉西他滨对人胰腺癌BxPC3细胞的生长抑制具有协同作用,其机制可能通过上调Bax基因表达,下调Bcl-2基因表达,降低Bcl-2/Bax比值而促进细胞凋亡所致. Objective To investigate the effect and mechanism of action in pancreatic cancer BxPC3 cell treated by cerulenin in combination with gemcitabine.Methods BxPC3 cells were cultivated with 10 μg/ml cerulenin,20 μmol/L gemcitabine or 10 μg/ml cerulenin + 20 μmol/L gemcitabine for 48 h,and cells without treatment were control.Cell proliferation was detected by CCK-8 assay,and early apoptosis was detected by AnnexinV/PI double staining method.The expression of Bcl-2 mRNA and Bax mRNA were detected by RT-PCR,and the protein level of Bcl-2,Bax were detected by Western Blot.Results The inhibition rate of BxPC3 cells were 0,(51.28 ± 1.84) %,(53.59 ± 1.62) %,(84.57 ± 1.01) % in control,cerulenin group,gemcitabine group,combination group; and the rate of early apoptosis was (0.83 ± 0.31) %,(31.37 ± 1.04) %,(38.33 ± 0.75) %,(69.43 ± 0.83) %,and the expression of Bcl-2 mRNA was 0.67 ± 0.01,0.44 ±0.01,0.36 ±0.08,0.27 ±0.07,and the expression of Bax mRNA was 0.14 ±0.01,0.31 ± 0.02,0.32 ± 0.03,0.91 ± 0.06 ; while the ratio of Bcl-2 mRNA/Bax mRNA was 4.78 ± 0.13,1.39 ± 0.04,1.15 ± 0.02,0.30 ± 0.02 ; the expression of Bcl-2 protein was 1.24 ± 0.04,0.51 ± 0.02,0.42 ± 0.02,0.13 ±0.01 ; and the expression of Bax protein was 0.20 ± 0.05,0.47 ± 0.01,0.54 ± 0.01,1.21 ± 0.03 ; while the ratio of Bcl-2/Bax was 6.00 ± 0.11,1.11 ± 0.01,0.77 ± 0.03,0.10 ± 0.06.And the difference among the groups was statistically significant (P < 0.01).Conclusions Cerulenin combined with gemcitabin has synergistic effect on the inhibition of BxPC cells proliferation.Its mechanisms may be up-regulation of Bax,down-regulation of Bcl-2,and promoting apoptosis of cells through the decrease of Bcl-2/Bax ratio.
出处 《中华胰腺病杂志》 CAS 2014年第5期307-311,共5页 Chinese Journal of Pancreatology
基金 苏州市社会发展项目(SYS201115)
关键词 胰腺肿瘤 浅蓝菌素 吉西他滨 药物协同作用 细胞凋亡 Pancreatic neoplasms Cerulenin Gemcitabine Drug synergism Apoptosis
  • 相关文献

参考文献13

  • 1Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007 [ J ]. CA Cancer J Clin, 2007, 57 ( 1 ) :43-66.
  • 2Sener SF, Fremgen A, Menck HR, et al. Pancreatic cancer: a report of treatment and survival trends for 100 313 patients diagnosed from 1985-1995, using the National Cancer Database [J]. JAmCollSurg, 1999,189(1):1-7.
  • 3Burris HA, Moore M J, Andersen J, et al. Improvements in survival and clinical benefit with gemcitabine as first-line therepy for patients with advanced pancreas cancer: a randomized trial [J]. J Clin Oncol, 1997, 15(6) :2403-2413.
  • 4Brerman MF. Adjuvant therapy following resection for pancreaticadenocarcinoma Surg[J]. Oncol Clin N Am, 2004, 13(4) :555-566.
  • 5Moore MJ, Goldstein D, Harem J, et al. Erlotinib plus gemeitabine compared with gemeitabine alone in patients with advanced pancreatic cancer: a phase m trial of the National Cancer Institute of Canada Clinical Trials Group [ J ]. J Clin Oncol, 2007, 25(5) : 1960-1966.
  • 6Van Cutsem E, Vervenne WL, Bennounal J, et al. Phase m trial of bevacizumab in combination with gemeitabine and erlotininb in patients with metastatic pancreatic cancer [ J ]. J Clin Oneol, 2009, 27(13): 2231-2237.
  • 7Pizer ES, Jackisch C, Wood FD, et al. Inhibition of fatty acid synthesis induces programmed ceil death in human breast cancer cells[ J]. Cancer Res, 1996, 56(12): 2745-2747.
  • 8Pizer ES, Wood FD, Heine HS, et al. Inhibition of fatty acid synthesis delays disease progression in a xenograft model of ovarian cancer[J]. Cancer Res, 1996, 56(6) : 1189-1193.
  • 9Lawrence DS, Zilfou JT, Smith CD, et al. Structure-activity studies of cerulenin analogues as protein palmitoylation inhibitors [J]. J Med Chem, 1999, 42(24) : 4932-4941.
  • 10Okawa Y, Hideshima T, Ikeda H, et al. Fatty acid synthase is a novel therapeutic target in multiple myeloma [ J ]. Br J Haematol, 2008, 141 (5) :659-671.

二级参考文献12

  • 1刘苗,董春燕,邹多武,李兆申,屠振兴.S100 mRNA在胰腺癌中的表达及其意义[J].胰腺病学,2006,6(4):230-232. 被引量:3
  • 2王炜琴,赵小英,徐根波,梁赟.脂肪酸合成酶抑制剂抑制人多发性骨髓瘤细胞增殖及诱导其凋亡的研究[J].中华血液学杂志,2006,27(10):675-677. 被引量:4
  • 3Brennan MF,Murray T,Xu J. Adjuvant therapy following resection for pancreatic adenocarcinoma[J].Surgical Oncology Clinics of North America,2004.555-566.
  • 4Ookhtens M,Kannan R,Lyon I. Liver and adipose tissue contributions to newly formed fatty acids in an ascites tumor[J].American Journal of Physiology,1984.146-153.
  • 5Uddin S,Jehan Z,Ahmed M. Overexpression of fatty acid synthase in Middle Eastern epithelial ovarian carcinoma activates AKT and Its inhibition potentiates cisplatin-induced apoptosis[J].Molecular Medicine,2011.635-645.
  • 6Lawrence DS,Zilfou JT,Smith CD. Structure-activity studies of cerulenin analogues as protein palmitoylation inhibitors[J].Journal of Medicinal Chemistry,1999.4932-4941.
  • 7Orita H,Coulter J,Lemmon C. Selective inhibition of fatty acid synthase for lung cancer treatment[J].Clinical Cancer Research,2007.7139-7145.
  • 8Orita H,Coulter J,Tully E. Inhibiting fatty acid synthase for chemoprevention of chemically induced lung tumors[J].Clinical Cancer Research,2008.2458-2464.
  • 9Okawa Y,Hideshima T,Ikeda H. Fatty acid synthase is a novel therapeutic target in multiple myeloma[J].British Journal of Haematology,2008.659-671.
  • 10Witkiewicz AK,Nguyen KH,Dasgupta A. Co-expression of fatty acid synthase and caveolin-1 in pancreatic ductal adenocarcinoma:implications for tumor progression and clinical outcome[J].CELL CYCLE,2008.3021-3025.

共引文献2

同被引文献9

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部